Moderna gets $50M investment for Ebola vaccine candidate
Summary
The Coalition for Epidemic Preparedness Innovations (CEPI) will invest $50 million to help Moderna develop and test a new vaccine against the Bundibugyo Ebola virus. This funding will also support making the vaccine and advancing later-stage testing if early results are promising.Key Facts
- CEPI is a global health organization focused on preparing for epidemics.
- Moderna is working on a vaccine targeting the Bundibugyo strain of the Ebola virus.
- Ebola is a deadly virus causing outbreaks in the Democratic Republic of Congo.
- The $50 million investment will support early clinical trials of the vaccine.
- If initial tests show the vaccine works, the money will help with manufacturing.
- Funding will also help move the vaccine into more advanced testing phases.
- The goal is to create a vaccine to control the current Ebola outbreak.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.